Positives

• Long COVID patients who started oral minocycline within 6 months of symptom onset describe significant relief of fatigue, post-exertional malaise, unrefreshing sleep, brain fog, orthostatic intolerance, and neuropathic pain on the 6-week course (100mg twice on day 1, then 100mg daily) PMC.

Negatives

• Some patients who tolerated minocycline without side effects still failed to respond, with poorer responses in those with longer disease duration — suggesting the “treatment window” for first-line use closes after roughly 6 months of illness PMC.
  
  

Hurdles & Side Effects

• Long-term minocycline carries a small but documented risk of drug-induced lupus and hyperpigmentation; specialists generally limit courses to 3-6 months and monitor for autoimmune flares throughout PMC.